دورية أكاديمية
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study
| العنوان: | Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study |
|---|---|
| المؤلفون: | Isfort, SusanneAff1, Aff2, IDs00277023053940_cor1, Manz, KirsiAff3, Aff4, Teichmann, Lino L.Aff2, Aff5, Crysandt, MartinaAff1, Aff2, Burchert, Andreas, Hochhaus, Andreas, Saussele, Susanne, Kiani, AlexanderAff9, Aff10, Göthert, Joachim R., Illmer, Thomas, Schafhausen, Philippe, Al-Ali, Haifa Kathrin, Stegelmann, Frank, Hänel, Mathias, Pfeiffer, Tim, Giagounidis, Aristoteles, Franke, Georg-Nikolaus, Koschmieder, SteffenAff1, Aff2, Fabarius, Alice, Ernst, Thomas, Warnken-Uhlich, Mareille, Wolber, Uta, Kohn, Denise, Pfirrmann, Markus, Wolf, DominikAff2, Aff5, Aff21, Brümmendorf, Tim H.Aff1, Aff2 |
| المصدر: | Annals of Hematology. :1-12 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 09395555 14320584 |
|---|---|
| DOI: | 10.1007/s00277-023-05394-0 |